Depression affects millions of people. The disorder can create havoc in the individual and everyone around them. While there are effective drug treatments, many have undesirable side effects. In addition, for some unknown reason the conventional anti-depressants gradually stop working. Therefore, pharmaceutical companies are continuously developing newer and better drugs.
Now there is a report from a phase ll clinical study that the stimulant drug (vyvnase) used to treat attention deficit hyperactive disorder, may help improve cognitive function in adults with depression. Vyvnase (lisdexamfetamine dimesylate) is currently approved by the FDA for use in adults and children with ADHD.
The recent study conducted by the manufacturer of the drug showed that some patients achieved partial or full remission of depression symptoms and improved cognitive function when Vyvnase was added to their daily treatment regimen.
No comments:
Post a Comment